Milestone Pharmaceuticals IncMIST
Price$0.82

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.8MTTM through 30 Jun 2026
Net Income -$84MTTM through 30 Jun 2026
Free Cash Flow -$61.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin94.1%
Operating Margin-9,942.4%
Net Margin-10,952.1%

Returns

-72.3%ROE
-46.3%ROA

Balance Sheet Health

Debt / Equity3.78x
Current Ratio9.18x
Net Debt-$47.9Mnet cash position
Cash & Equivalents$169.7M

Quality Metrics

Altman Z-Score-3.69
Piotroski F-Score2 / 9
FCF Margin-3,455.5%
Earnings-Beat Rate50.0%

Multi-Year Trend

Diluted EPS-$0.65TTM
'20'21'22'23'24'25
FY2025: $-0.75

Dividend

No dividend

Capital Allocation

Capex Intensity149.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.